Doctors Note Logo

Published on: 9/13/2026

What tests do doctors use to diagnose ALS in women in their 30s and 40s?

There is no single test for ALS; doctors diagnose it by ruling out other conditions using electromyography (EMG) and nerve conduction studies, MRI of the brain and spine, blood and urine tests, and sometimes a spinal tap, muscle or nerve biopsy, or genetic testing. In younger women, clinicians often first exclude mimics such as multiple sclerosis, myasthenia gravis, thyroid disease, Lyme disease, vitamin B12 deficiency, and cervical spine compression, which can delay a definitive answer. Several factors affect which tests are ordered and how results are interpreted, so see below for the important details.

Because early ALS symptoms like limb weakness, muscle twitching, cramping, or slurred speech overlap with many far more common and treatable conditions, understanding your specific pattern of symptoms is the fastest way to know what to raise with a neurologist. Take a free, instant, online symptom check to see which conditions may explain what you are feeling and what steps to take next.

Last reviewed for medical accuracy: 09/12/2026

answer background

Explanation

Diagnosis of amyotrophic lateral sclerosis (ALS) in women in their 30s and 40s follows the same step-by-step approach used for all adults, with extra care given to ruling out conditions that mimic early ALS. Because ALS is relatively rare in younger adults, doctors aim to exclude other causes of muscle weakness and nerve dysfunction before confirming ALS. Here’s how the process typically works.

  1. Detailed medical history and physical exam
    • Gather symptom timeline: onset of muscle twitching (fasciculations), weakness, stiffness or cramps.
    • Note pattern: are symptoms affecting one limb first, or more widespread?
    • Family history: about 5–10% of ALS cases are inherited, so questions about relatives with neuromuscular disease are key.
    • Neurological exam: tests strength, reflexes, muscle tone and coordination. Hyperactive reflexes and signs of both upper motor neuron (spasticity, brisk reflexes) and lower motor neuron (fasciculations, muscle atrophy) involvement raise suspicion.

  2. Electrophysiological studies
    Electrophysiology is central to supporting an ALS diagnosis, by detecting denervation (loss of nerve supply) and re-innervation changes in muscles.
    • Electromyography (EMG)
    – A thin needle electrode is inserted into multiple muscles to record electrical activity at rest and during contraction.
    – In ALS, EMG shows evidence of chronic denervation (large, erratic motor unit potentials) and acute denervation (fibrillation potentials, positive sharp waves).
    – Examines muscles in multiple body regions—arms, legs, trunk and bulbar (speech/swallow) muscles—to meet diagnostic criteria.
    • Nerve conduction studies (NCS)
    – Measures speed and strength of electrical signals in peripheral nerves.
    – In ALS, motor conduction may be mildly slowed, but sensory conduction is typically normal.
    – Helps rule out peripheral neuropathies or multifocal motor neuropathy, which can present similarly.

  3. Magnetic resonance imaging (MRI)
    Although MRI cannot diagnose ALS directly, it rules out other conditions such as cervical spinal cord compression, multiple sclerosis or brain tumors.
    • Brain MRI
    – Looks for lesions or structural issues in the motor cortex that might explain symptoms.
    – Normal or nonspecific findings support an ALS workup when combined with clinical and EMG data.
    • Spinal MRI
    – Examines cervical, thoracic and lumbar spine for herniated discs or syringomyelia (fluid-filled cavities) that mimic motor neuron disease.

  4. Laboratory tests
    A panel of blood and urine tests excludes metabolic, infectious or inflammatory disorders. Common tests include:
    • Complete blood count (CBC) and basic metabolic panel
    • Thyroid function tests (to rule out thyroid disease)
    • Vitamin B12 and folate levels
    • Creatine kinase (CK)
    – Elevated CK can occur in ALS but is nonspecific. Very high CK may suggest muscular dystrophy or inflammatory myopathy.
    • Autoimmune markers (e.g., antinuclear antibodies)
    • Infectious workup (e.g., HIV, Lyme disease)

  5. Cerebrospinal fluid (CSF) analysis
    In certain cases, especially if brain or spinal MRI shows atypical changes, a lumbar puncture (spinal tap) is performed. CSF testing can detect:
    • Inflammatory markers or oligoclonal bands (suggestive of multiple sclerosis)
    • Infections (e.g., Lyme, viral causes)
    • Protein levels that might point to other neurologic diseases

  6. Genetic testing
    Because early-onset ALS (before age 50) has a higher chance of a genetic cause, doctors may recommend testing for known ALS-related gene mutations, such as:
    • C9orf72 hexanucleotide repeat expansion
    • SOD1, TARDBP, FUS and other less common genes
    Genetic counseling is crucial before and after testing to understand implications for family members and future health planning.

  7. Muscle biopsy (select cases)
    A muscle biopsy is rarely required for ALS diagnosis but may be done if EMG or blood tests suggest an inflammatory myopathy or metabolic muscle disease. A small piece of muscle is removed under local anesthesia and examined under a microscope to look for:
    • Inflammation or autoimmune features
    • Abnormal muscle fibers or storage material
    • Denervation changes supporting a motor neuron process

  8. Applying diagnostic criteria
    Neurologists use standardized guidelines—such as the revised El Escorial and Awaji criteria—to combine clinical findings, EMG/NCS results and imaging. These criteria classify ALS as “definite,” “probable” or “possible,” based on how many regions of the nervous system show both upper and lower motor neuron signs.

  9. Multidisciplinary evaluation
    Once ALS is confirmed, a team approach improves care and quality of life. Specialists may include:
    • Neurologist (with ALS expertise)
    • Physical and occupational therapists
    • Speech therapist (for bulbar symptoms)
    • Respiratory therapist (for breathing support)
    • Registered dietitian
    • Social worker or counselor

Tips for Women in Their 30s and 40s
• Early and accurate diagnosis reduces stress and speeds up access to care.
• Track symptoms closely—note when weakness or twitching started, how it’s progressed, and any patterns.
• Keep a symptom diary to share with your neurologist.
• Don’t hesitate to seek a second opinion at a specialized ALS center if there’s uncertainty.

When to Seek Medical Advice
If you notice persistent muscle weakness, cramps, twitching or changes in speech or swallowing, it’s important to get checked. Early evaluation by a neurologist helps rule out treatable conditions and guides timely support.

Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you organize your symptoms before your appointment.

Speak to a doctor about any symptoms that could be serious or life-threatening. Early consultation is key to getting the right diagnosis and care plan.

Key Takeaways
• No single test confirms ALS—diagnosis relies on clinical exam, EMG/NCS, imaging and lab studies.
• Genetic testing is more common in younger adults with ALS symptoms.
• Ruling out other conditions is a critical first step.
• Multidisciplinary care improves outcomes and quality of life.
• Always follow up with a neurologist if you have concerning muscle or nerve symptoms.

This comprehensive approach ensures that women in their 30s and 40s receive a thorough, accurate evaluation for ALS while minimizing anxiety and unnecessary procedures. If you’re worried about your symptoms or need guidance, start with a neurologist and consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. Remember, nothing replaces professional medical advice—speak to a doctor for personalized care.

(References)

  • * Gordon PH, Mitsumoto H, Hays AP. Amyotrophic lateral sclerosis. Sci Aging Knowledge Environ. 2003 Sep 3;2003(35):dn2. doi: 10.1126/sageke.2003.35.dn2. Epub 2003 Sep 3. PMID: 12954882.

  • * Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobáGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174. doi: 10.1080/21678421.2016.1267768. Epub 2017 Jan 5. PMID: 28054827; PMCID: PMC7409990.

  • * van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques. Int J Mol Sci. 2019 Jun 10;20(11). doi: 10.3390/ijms20112818. Epub 2019 Jun 10. PMID: 31185581; PMCID: PMC6600525.

  • * Papadopoulou M, Bakola E, Papapostolou A, Stefanou MI, Moschovos C, Salakou S, Zis P, Zouvelou V, Kimiskidis VK, Chroni E, Tsivgoulis G. Autonomic dysfunction in amyotrophic lateral sclerosis: A neurophysiological and neurosonology study. J Neuroimaging. 2022 Jul;32(4):710-719. doi: 10.1111/jon.12993. Epub 2022 Mar 28. PMID: 35344230.

  • * Yaguchi H, Sakuta K, Mukai T, Miyagawa S. Fiberoptic laryngoscopic neurological examination of amyotrophic lateral sclerosis patients with bulbar symptoms. J Neurol Sci. 2022 Sep 15;440:120325. doi: 10.1016/j.jns.2022.120325. Epub 2022 Jun 18. PMID: 35779417.

  • * Liu S, Sun X, Ren Q, Chen Y, Dai T, Yang Y, Gong G, Li W, Zhao Y, Meng X, Lin P, Yan C. Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis. Brain. 2024 Jan 4;147(1):100-108. doi: 10.1093/brain/awad274. PMID: 37584389.

  • * Sharkey RJ, Cortese F, Goodyear BG, Korngut LW, Jacob SM, Sharkey KA, Kalra S, Nguyen MD, Frayne R, Pfeffer G. Longitudinal analysis of glymphatic function in amyotrophic lateral sclerosis and primary lateral sclerosis. Brain. 2024 Dec 3;147(12):4026-4032. doi: 10.1093/brain/awae288. PMID: 39241118; PMCID: PMC11629681.

  • * van den Bos MAJ, Menon P, Pavey N, Higashihara M, Kiernan MC, Vucic S. Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis. Brain. 2025 Apr 3;148(4):1169-1179. doi: 10.1093/brain/awae317. PMID: 39385724.

  • * Farahani A, Hansen JY, Bazinet V, Shafiei G, Collins DL, Dadar M, Kalra S, Dagher A, Misic B. Network spreading and local biological vulnerability in amyotrophic lateral sclerosis. Commun Biol. 2025 Aug 4;8(1):1153. doi: 10.1038/s42003-025-08561-3. Epub 2025 Aug 4. PMID: 40760014; PMCID: PMC12322078.

  • * Freri F, Spinelli EG, Canu E, Basaia S, Castelnovo V, Müller HP, Kassubek J, Ludolph AC, Krishnamurthy SS, Roselli F, Filippi M, Agosta F. Uncovering hypothalamic network disruption in ALS. J Neurol. 2025 Dec 22;273(1):37. doi: 10.1007/s00415-025-13574-3. Epub 2025 Dec 22. PMID: 41428120; PMCID: PMC12722382.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.